{"id":535103,"date":"2021-09-07T16:08:47","date_gmt":"2021-09-07T20:08:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/"},"modified":"2021-09-07T16:08:47","modified_gmt":"2021-09-07T20:08:47","slug":"spruce-biosciences-to-participate-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/","title":{"rendered":"Spruce Biosciences to Participate in September Investor Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Spruce Biosciences to Participate in September Investor Conferences<\/b><\/p>\n<p>SAN FRANCISCO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sprucebiosciences.com%2F&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Spruce+Biosciences%2C+Inc&amp;index=1&amp;md5=def92c76c45218bd2b5d1b80748f834f\">Spruce Biosciences, Inc<\/a>. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in four upcoming investor conferences taking place virtually throughout the month of September:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>H.C. Wainwright 23rd Annual Global Investment Conference<br \/>\n<br \/>Date: <\/b>September 13 \u2013 14, 2021<br \/>\n<br \/><b>Format:<\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fjourney.ct.events%252Fview%252F709a4105-61e6-4d46-8bc3-41275db23f5e%26data%3D04%257C01%257Csgharib%2540sprucebiosciences.com%257C6a495e542e814811e5f408d96e80475f%257C56445706c3694e23a09bd09723fd5573%257C0%257C0%257C637662319974821440%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C2000%26sdata%3DEyuAUN2VrfX3c238C8HVJeqhtLvRz7gR1xQfc%252BhJWBs%253D%26reserved%3D0&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Company+presentation&amp;index=2&amp;md5=0524a9bbf64db89cca931c53f537a7a0\">Company presentation<\/a> (available September 13 at 7:00 am ET) and 1&#215;1 meetings\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Baird 2021 Global Healthcare Conference<br \/>\n<br \/>Date:<\/b> September 14 \u2013 15, 2021<br \/>\n<br \/><b>Format:<\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Fbaird-2021-global-healthcare-conference%2Fspruce-biosciences-inc-sept&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Company+presentation&amp;index=3&amp;md5=726d9c7a308a4ba64b066486619de0b0\">Company presentation<\/a> (September 15 at 1:25 pm ET) and 1&#215;1 meetings\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit<br \/>\n<br \/>Date:<\/b> September 20 \u2013 22, 2021<br \/>\n<br \/><b>Format:<\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Foppenheimer16%2Fsprb%2F2797541&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Company+presentation&amp;index=4&amp;md5=89e67ae266bc58cbbdbf6e9665f6a015\">Company presentation<\/a> (September 21 at 11:35 am ET) and 1&#215;1 meetings\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases &amp; Genetic Medicines 1&#215;1 Event<br \/>\n<br \/>Date:<\/b> September 22 \u2013 23, 2021<br \/>\n<br \/><b>Format:<\/b> 1&#215;1 meetings\n<\/li>\n<\/ul>\n<p>\nInterested parties can access the webcast for each conference presentation from the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.sprucebiosciences.com%2Fnews-and-events%2Fevents&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Events&amp;index=5&amp;md5=8d710abef4728fed6ceed272f000dd4a\">Events<\/a> section of the company\u2019s <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.sprucebiosciences.com%2Fnews-and-events%2Fevents&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=investor+relations+website&amp;index=6&amp;md5=de68833f767aaf3498ecd9fb36f2a162\">investor relations website<\/a>.<b \/><\/p>\n<p><b>About Spruce Biosciences<\/b><\/p>\n<p>\nSpruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sprucebiosciences.com&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=www.sprucebiosciences.com&amp;index=7&amp;md5=ce6bb18872f44768126ddd0a378523af\">www.sprucebiosciences.com<\/a> and follow us on Twitter @<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fspruce_bio&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Spruce_Bio&amp;index=8&amp;md5=1bd3ec2c196f581d9cd25b9471204d55\">Spruce_Bio<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fspruce-biosciences%2F&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=9&amp;md5=84c70801e8b96593c8db1bd8319e4d97\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FSpruceBio%2F&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=Facebook&amp;index=10&amp;md5=4edfad898b7d7238f2293d9d2633482e\">Facebook<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCiPbmokQUFy9wc3wvY5PZnw&amp;esheet=52487394&amp;newsitemid=20210907005724&amp;lan=en-US&amp;anchor=YouTube&amp;index=11&amp;md5=f1f465b09bafbfa93b22d0568b12352a\">YouTube<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210907005724\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210907005724\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact<\/b><\/p>\n<p>\nWill Zasadny<br \/>\n<br \/>Canale Communications<br \/>\n<br \/>(619) 961-8848<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:will.zasadny@canalecomm.com\">will.zasadny@canalecomm.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"mailto:media@sprucebiosciences.com\">media@sprucebiosciences.com<\/a><\/p>\n<p><b>Investors<\/b><\/p>\n<p>\nXuan Yang<br \/>\n<br \/>Solebury Trout<br \/>\n<br \/>(415) 971-9412<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:xyang@soleburytrout.com\">xyang@soleburytrout.com<br \/>\n<\/a><span class=\"bwuline\"><br \/><\/span><a rel=\"nofollow\" href=\"mailto:investors@sprucebiosciences.com\">investors@sprucebiosciences.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210907005724\/en\/789688\/3\/Picture1.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Spruce Biosciences to Participate in September Investor Conferences SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in four upcoming investor conferences taking place virtually throughout the month of September: H.C. Wainwright 23rd Annual Global Investment Conference Date: September 13 \u2013 14, 2021 Format:Company presentation (available September 13 at 7:00 am ET) and 1&#215;1 meetings Baird 2021 Global Healthcare Conference Date: September 14 \u2013 15, 2021 Format:Company presentation (September 15 at 1:25 pm ET) and 1&#215;1 meetings Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit Date: September 20 \u2013 22, 2021 Format:Company presentation (September 21 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spruce Biosciences to Participate in September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535103","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Spruce Biosciences to Participate in September Investor Conferences SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in four upcoming investor conferences taking place virtually throughout the month of September: H.C. Wainwright 23rd Annual Global Investment Conference Date: September 13 \u2013 14, 2021 Format:Company presentation (available September 13 at 7:00 am ET) and 1&#215;1 meetings Baird 2021 Global Healthcare Conference Date: September 14 \u2013 15, 2021 Format:Company presentation (September 15 at 1:25 pm ET) and 1&#215;1 meetings Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit Date: September 20 \u2013 22, 2021 Format:Company presentation (September 21 &hellip; Continue reading &quot;Spruce Biosciences to Participate in September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T20:08:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spruce Biosciences to Participate in September Investor Conferences\",\"datePublished\":\"2021-09-07T20:08:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/\",\"name\":\"Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-07T20:08:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spruce Biosciences to Participate in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk","og_description":"Spruce Biosciences to Participate in September Investor Conferences SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in four upcoming investor conferences taking place virtually throughout the month of September: H.C. Wainwright 23rd Annual Global Investment Conference Date: September 13 \u2013 14, 2021 Format:Company presentation (available September 13 at 7:00 am ET) and 1&#215;1 meetings Baird 2021 Global Healthcare Conference Date: September 14 \u2013 15, 2021 Format:Company presentation (September 15 at 1:25 pm ET) and 1&#215;1 meetings Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit Date: September 20 \u2013 22, 2021 Format:Company presentation (September 21 &hellip; Continue reading \"Spruce Biosciences to Participate in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T20:08:47+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spruce Biosciences to Participate in September Investor Conferences","datePublished":"2021-09-07T20:08:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/","name":"Spruce Biosciences to Participate in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-07T20:08:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005724r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spruce Biosciences to Participate in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535103"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535103\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}